Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPARE trial: spironolactone versus amiloride for resistant hypertension
KCT0004891Phase 4Recruiting
- Sponsor
- Yonsei University Health System
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in resistant hypertension (RH) comparing spironolactone arm with amiloride arm (2 arms). Primary endpoint: Home blood pressure change. Started Nov 2020; status: recruiting.
02
Drugs
spironolactoneamiloride
03
Conditions
resistant hypertension (RH)
Beyond the preview
Go deeper on KCT0004891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004891.